Please check your internet connection and try again.
# Arsilate (Arsil)
## Overview
Arsilate is a salicylate derivative, chemically related to aspirin, primarily used for its analgesic, antipyretic, and anti-inflammatory properties. It is often formulated as a sustained-release or buffered tablet.
## Primary Indications
* Management of mild to moderate pain.
* Symptomatic relief of rheumatoid arthritis, osteoarthritis, and other inflammatory conditions.
## Adult Dosing
* **Analgesic/Antipyretic:** 325 mg to 650 mg orally every 4 to 6 hours as needed.
* **Anti-inflammatory:** 650 mg to 1,000 mg orally 3 to 4 times daily.
* **Maximum Daily Dose:** Do not exceed 4,000 mg in 24 hours to avoid salicylate toxicity.
## Pediatric Dosing
* **General Use:** Not routinely recommended in children/adolescents due to the risk of Reye's syndrome (associated with salicylate use during viral infections, e.g., influenza, varicella).
* **RA/JIA:** If deemed necessary by a rheumatologist, dosing is typically 60–90 mg/kg/day divided every 6–8 hours. Use is specialized; consult pediatric rheumatology protocols.
## Dose Adjustments
* **Renal Impairment:** Exercise caution; reduced dosing may be required to prevent accumulation. Monitor creatinine clearance.
* **Hepatic Impairment:** Use with caution; monitor liver function tests (LFTs). Avoid in severe liver disease.
* **Geriatric:** Start at the lower end of the dosing range due to increased risk of GI bleeding and impaired renal clearance.
## Contraindications
* Hypersensitivity to salicylates or NSAIDs.
* Active peptic ulcer disease or GI bleeding.
* Bleeding disorders (e.g., hemophilia, thrombocytopenia).
* Children or teenagers with viral infections (risk of Reye's syndrome).
* History of asthma/nasal polyps induced by aspirin.
## Adverse Effects
* **Common:** Dyspepsia, nausea, abdominal pain.
* **Serious:** GI ulceration, hemorrhage, tinnitus (sign of salicylism), hepatotoxicity, renal impairment, bronchospasm.
* **Overdose:** Hyperventilation, respiratory alkalosis followed by metabolic acidosis, tinnitus, hyperthermia.
## Key Drug Interactions
* **Anticoagulants/Antiplatelets (e.g., Warfarin, Rivaroxaban):** Significantly increases risk of major bleeding.
* **NSAIDs:** Increases risk of GI toxicity and erosive gastritis.
* **Corticosteroids:** Concomitant use increases the risk of gastric ulceration.
* **Methotrexate:** Increases risk of methotrexate toxicity due to decreased renal excretion.
* **Alcohol:** Increases risk of GI bleeding.
## Monitoring
* **Long-term:** CBC (for anemia), renal function (BUN/SCr), and LFTs.
* **Safety:** Monitor for signs of GI bleeding (melena, hematemesis) and salicylism (tinnitus, vertigo, nausea, or confusion).
## Clinical Pearls
* Salicylates exhibit zero-order kinetics at higher doses, meaning small increases in dose can lead to disproportionate increases in serum concentration and risk of toxicity.
* Always advise patients to take with food or milk to minimize gastric irritation.
* Discontinue use 5–7 days prior to elective surgery due to antiplatelet effects.
* Individual protocols vary significantly; verify specific institutional guidelines for rheumatic conditions and pediatric oversight.
***
**Educational Disclaimer:** This information is for educational purposes and does not substitute for professional medical judgment. Always verify current prescribing information (package insert) and institutional dosing protocols before ordering or administering any medication.
